Fever is a common symptom encountered in clinical practice, often indicative of an underlying infectious, inflammatory, or neoplastic process. Despite its frequency, the management of fever remains complex, due to its diverse etiologies and the need for individualized patient care.
Understanding the pathophysiology of fever is the first step towards effective management. Fever is a regulated elevation in body temperature, triggered by pyrogens that act on the hypothalamus. Pyrogens can be exogenous, such as microbial toxins, or endogenous, like cytokines produced during inflammation.
A thorough history and physical examination are essential in the diagnostic evaluation of fever. The history should focus on the onset, pattern, duration of fever, and associated symptoms. It is also important to consider the patient's recent travel, exposure to infectious agents, and underlying health conditions. Laboratory and imaging studies should be guided by clinical suspicion.
Treatment of fever should be directed towards the underlying cause. Antipyretics can be used to alleviate discomfort, but should not replace the need for a definitive diagnosis and treatment. In cases where the cause of fever is undetermined, a systematic approach should be taken to rule out potential sources of infection or non-infectious causes.
While antipyretics are commonly used in fever management, their role is primarily symptomatic. They do not address the underlying cause of fever, and their overuse can mask symptoms and delay diagnosis. Therefore, their use should be judicious, especially in patients with severe or persistent fever.
Fever management in clinical practice is a complex process that requires a comprehensive approach. Understanding the pathophysiology of fever, conducting a thorough diagnostic evaluation, and formulating an appropriate treatment strategy are crucial. While antipyretics can provide symptomatic relief, they should not overshadow the need for identifying and treating the underlying cause of fever.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation